INSP — Inspire Medical Systems, Inc. stock price, charts and financials

QT57Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc. (NYSE: INSP) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
60.72
+0.55+0.92%
OverviewShort InterestFilings
INSPQT57Inspire Medical Systems, Inc.·NYSE
60.72+0.92%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
NVCR+6.04%$17.38TNDM-0.07%$22.36ENOV-5.77%$25.07CNMD+1.34%$49.78ATEC+0.14%$9.32IART+0.20%$17.29ESTA-0.98%$76.66AORT-1.92%$26.60
Snapshot
Index-P/E12.91EPS (ttm)4.66Insider Own2.38%Shs Outstand28.91MPerf Week19.82%
Market Cap1.74BForward P/E40.92EPS next Y1.47Insider Trans-0.59%Shs Float27.25MPerf Month16.77%
Enterprise Value1.64BPEG0.08EPS next Q-Inst Own-Short Float15.94%Perf Quarter32.02%
Income135.31MP/S1.94EPS this Y-73.41%Inst Trans-Short Ratio3.77Perf Half Y-8.29%
Sales898.75MP/B2.10EPS next Y23.15%ROA14.58%Short Interest4.34MPerf YTD-34.77%
Book/sh-P/C11.04EPS next 5Y28.31%ROE17.62%52W High148.37 -59.08%Perf Year-23.31%
Cash/sh-P/FCF14.85EPS past 3/5Y-ROIC6.33%52W Low39.27 54.61%Perf 3Y-78.35%
Dividend Est.-EV/EBITDA19.74Sales past 3/5Y30.75% 51.31%Gross Margin86.13%Volatility5.66% 4.61%Perf 5Y-67.15%
Dividend TTM-EV/Sales1.83EPS Y/Y TTM156.57%Oper. Margin6.02%ATR (14)3.11Perf 10Y-
Dividend Ex-DateJan 09, 2008Quick Ratio6.16Sales Y/Y TTM14.07%Profit Margin15.03%RSI (14)65.15Recom2.59
Dividend Gr. 3/5Y-Current Ratio8.55EPS Q/Q0.00%SMA2013.62%Beta0.69Target Price61.08
Payout0.00%Debt/Eq0.04Sales Q/Q1.99%SMA5026.60%Rel Volume0.50Prev Close60.16
Employees1,333LT Debt/Eq0.04EarningsNov 02SMA200-11.89%Avg Volume1.07MPrice60.72
IPO DateMay 03, 2018Option/ShortYes / YesEPS/Sales Surpr.136.32% 2.27%Net Debt/EBITDA-1.19Volume538,852Change0.92%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-04-26ReiteratedRBC CapitalSector Perform$45 → $60
Aug-04-26ReiteratedStifel NicolausBuy$65 → $75
Aug-04-26ReiteratedRobert W. Baird$54 → $59
Aug-04-26ReiteratedPiper SandlerNeutral$55 → $60
Aug-04-26UpgradeOppenheimerPerform → Outperform$175 → $85
Aug-04-26ReiteratedTruist SecuritiesHold$54 → $62
Aug-04-26ReiteratedEvercore ISI GroupIn Line$40 → $54
Jul-28-26ReiteratedUBSNeutral$67 → $39
Jul-16-26ReiteratedTruist SecuritiesHold$50 → $54
Jun-23-26DowngradeEvercore ISI GroupOutperform → In Line$55 → $40
Latest News
Aug-05-26
Aug-05-2603:01PM
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?zacks.com
03:01PM
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Easezacks.com
02:36PM
INSP's 28.1% Past-Month Rally Raises a Key Question for Investorszacks.com
03:07AM
Amundi Sells 107,792 Shares of Inspire Medical Systems, Inc. $INSPdefenseworld.net
Aug-04-26
Aug-04-2602:01PM
Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Upzacks.com
10:00AM
Caterpillar, Wayfair, Zebra Technologies, Gartner And Other Big Stocks Moving Higher On TuesdayBenzinga
08:14AM
Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Resultsbenzinga.com
02:30AM
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcriptseekingalpha.com
Aug-03-26
Aug-03-2608:05PM
Inspire Medical Systems Q2 Earnings Call Highlightsmarketbeat.com
07:01PM
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metricszacks.com
06:46PM
Inspire Medical Systems (INSP) Q2 Earnings and Revenues Beat Estimateszacks.com
04:02PM
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Planglobenewswire.com
Jul-29-26
Jul-29-2604:03AM
Inspire Medical Systems, Inc. $INSP Stake Boosted by Bank of Nova Scotiadefenseworld.net
Jul-28-26
Jul-28-2612:51PM
UBS Assumes Inspire Medical Systems at Sell, Lowers Price Target of $39Benzinga
Jul-27-26
Jul-27-2608:00AM
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directorsglobenewswire.com
Company

Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue916912803——————
Cost of Goods Sold Incl. D&A131133123——————
Gross Profit785779680——————
Selling, General and Administrative Excl. Other633625530——————
Research and Development101103114——————
Other Operating Expense
000——————
Operating Income525136——————
Interest Expense
000——————
Unusual Expense
—————————
Non-Operating Income (Expense)131522——————
Net Income Before Taxes646658——————
Income Taxes-67-805——————
Consolidated Net Income13114554——————
Net Income From Continuing Operations13114554——————
Net Income13114554——————
EPS (Recurring)4.534.951.80——————
EPS (Basic, Before Extraordinaries)4.534.951.80——————
EPS (Diluted)4.494.891.75——————
EBITDA808065——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio13.5218.86105.93——————
Price To Sales Ratio1.922.936.93——————
Gross Margin85.7085.4284.68——————
Operating Margin5.685.594.48——————
Net Margin14.3015.906.72——————
Shares Outstanding292930——————
Market Capitalization1,7612,6755,561——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$159.58$125.80$92.02$58.24$24.46● Close Price0.00M0.26M0.51M0.77M1.03MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Rondoni JohnSee RemarksMay 15 '26Sale43.282,641114,30227,165May 19
Rondoni JohnSee RemarksMay 14 '26Sale43.0170030,10729,806May 15
mcCormick ShawnDirectorMay 08 '26Sale45.3169631,53627,712May 11
Rondoni JohnSee RemarksJan 09 '26Sale100.0010910,90013,797Jan 12
mcCormick ShawnDirectorDec 02 '25Sale139.001,200166,80024,846Dec 04
mcCormick ShawnDirectorNov 28 '25Sale127.482,000254,96026,046Dec 01
Curet MyriamDirectorAug 08 '25Sale77.2843093,365Nov 24
Curet MyriamDirectorMay 08 '25Sale153.2223063,369Nov 24
Curet MyriamDirectorApr 07 '25Buy148.2611483,371Nov 24
Curet MyriamDirectorMar 20 '25Buy163.8446553,370Nov 24
Buchholz RichardChief Financial OfficerAug 29 '25Sale93.3911,0001,027,29044,867Sep 02
Buchholz RichardChief Financial OfficerAug 19 '25Option Exercise62.7425,0081,569,03161,247Aug 21
mcCormick ShawnDirectorJun 04 '25Option Exercise16.004,00064,00028,046Jun 06
Rondoni JohnSee RemarksMay 19 '25Sale149.381,734259,02513,766May 21
mcCormick ShawnDirectorMay 02 '25Sale160.0036057,60024,046May 05
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.